naltrexone has been researched along with Disorder, Borderline Personality in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Enning, F; Schmahl, C | 1 |
| García, MC | 1 |
| Bandelow, B; Meiser, M; Timäus, C; Wedekind, D; Wiltfang, J | 1 |
| DeLucia, B | 1 |
| Carmona, C; Elices, M; Gasol, M; Gasol, X; Martín-Blanco, A; Pascual, JC; Patrizi, B; Soler, J | 1 |
| Berger, M; Bohus, M; Brünen, S; Deibler, P; Herpertz, S; Hiemke, C; Kleindienst, N; Lieb, K; Limberger, M; Ludäscher, P; Mauchnik, J; Reicherzer, M; Schmahl, C | 1 |
| Brady, K; Malcolm, R; Morris, T; Rubey, R; Sonne, S | 1 |
| Hoffman, RE; Ostroff, RB; Roth, AS | 1 |
| McGee, MD | 1 |
| Böhme, R; Bohus, M; Schmahl, C; Stiglmayr, C | 1 |
| Böhme, R; Bohus, MJ; Landwehrmeyer, GB; Limberger, MF; Schmahl, CG; Stiglmayr, CE | 1 |
| Bohus, M; Schmahl, C | 1 |
| Saper, JR | 1 |
| Bolm, T; Piegler, T | 1 |
1 review(s) available for naltrexone and Disorder, Borderline Personality
| Article | Year |
|---|---|
[Treatment of borderline personality disorder with opioid antagonists: buprenorphine, nalmefene, naloxone and naltrexone in the treatment of dissociative symptoms, self-mutilation and suicidal behavior].
Topics: Borderline Personality Disorder; Buprenorphine; Dissociative Disorders; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Observational Studies as Topic; Self Mutilation; Suicidal Ideation | 2020 |
5 trial(s) available for naltrexone and Disorder, Borderline Personality
| Article | Year |
|---|---|
Use of nalmefene in patients with comorbid borderline personality disorder and alcohol use disorder: a preliminary report.
Topics: Adult; Alcoholism; Borderline Personality Disorder; Comorbidity; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Research Report | 2017 |
Evaluation of naltrexone for dissociative symptoms in borderline personality disorder.
Topics: Adolescent; Adult; Borderline Personality Disorder; Double-Blind Method; Female; Germany; Humans; Naltrexone; Narcotic Antagonists; Placebos; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Young Adult | 2012 |
Naltrexone treatment of self-injurious thoughts and behaviors.
Topics: Adult; Borderline Personality Disorder; Circadian Rhythm; Female; Humans; Naltrexone; Personality Inventory; Pilot Projects; Psychiatric Status Rating Scales; Self-Injurious Behavior; Treatment Outcome | 1996 |
Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
Topics: Adolescent; Adult; Borderline Personality Disorder; Dose-Response Relationship, Drug; Emotions; Female; Follow-Up Studies; Humans; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Pain Measurement; Recurrence; Self-Injurious Behavior; Treatment Outcome | 1996 |
Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.
Topics: Adolescent; Adult; Borderline Personality Disorder; Comorbidity; Dissociative Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Germany; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Personality Inventory; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 1999 |
8 other study(ies) available for naltrexone and Disorder, Borderline Personality
| Article | Year |
|---|---|
[Treatment of dissociative symptoms with nalmefene in patients with borderline personality disorder and complex posttraumatic stress disorder].
Topics: Borderline Personality Disorder; Dissociative Disorders; Humans; Naltrexone; Stress Disorders, Post-Traumatic | 2022 |
Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients.
Topics: Borderline Personality Disorder; Humans; Inpatients; Naltrexone; Narcotic Antagonists; Retrospective Studies | 2021 |
Naltrexone for Self-Injury in Borderline Personality With Venlafaxine-Associated Hyponatremia.
Topics: Adult; Antidepressive Agents, Second-Generation; Borderline Personality Disorder; Female; Humans; Hyponatremia; Naltrexone; Narcotic Antagonists; Self-Injurious Behavior; Venlafaxine Hydrochloride | 2017 |
Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone.
Topics: Adult; Alcoholism; Borderline Personality Disorder; Female; Humans; Naltrexone; Self Mutilation | 1997 |
[Treatment of dissociative symptoms in borderline patients with naltrexone].
Topics: Adult; Borderline Personality Disorder; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Neurobehavioral Manifestations | 1999 |
[Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments].
Topics: Borderline Personality Disorder; Dissociative Disorders; Drug Administration Schedule; Female; Humans; Naltrexone; Narcotic Antagonists; Self-Injurious Behavior; Treatment Outcome | 2000 |
Borderline personality, opioids, and naltrexone.
Topics: Borderline Personality Disorder; Headache; Humans; Naltrexone; Narcotic Antagonists; Narcotics; Pain, Intractable | 2000 |
[Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders].
Topics: Adult; Borderline Personality Disorder; Combined Modality Therapy; Depression; Dissociative Disorders; Female; Humans; Naltrexone; Narcotic Antagonists; Psychotherapeutic Processes; Psychotherapy; Self-Injurious Behavior; Stress Disorders, Post-Traumatic; Treatment Outcome | 2001 |